Building a Healthy Body after Cancer: Challenges and Opportunities in Healthy Exercise after Treatment for Young Adult Lymphoma Survivors
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 16-001843
Sponsor Protocol Number: 16-001843
About this study
Exercise can benefit young adult cancer survivors by improving cardiovascular and pulmonary function, reducing fatigue, improving quality of life, and may even increase long term survival. Our goal is to identify specific barriers to exercise faced by young adult lymphoma survivors. In addition, we will look to survivors to guide us on the particular ways in which a health care institution might support them in physical activity. Our specific aims are: evaluate young adult lymphoma survivors’ knowledge regarding benefits of exercise after cancer treatment, identify barriers to exercise experienced by young adult lymphoma survivors, and understand the types of exercise interventions that may be useful in young adult lymphoma survivors
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Patients previously diagnosed with lymphoma
- Ages 18-35
- Live within 120 miles of Mayo Clinic, Rochester
- 6 months to 5 years post-treatment, as well as those in disease remission who are being treated with immunotherapies like Nivolumab
Exclusion Criteria:
- Patients currently being treated with cytotoxic chemotherapy
- Patients less than age 18 years or more than age 35 years
- Patients who do not speak English
- Patients who are incarcerated
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Carrie Thompson, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available